Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 18 -0.10 (-0.55%)
As of 02/21/2025 11:46 AM Eastern

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, APH, AGY, and HZD

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Alliance Pharma (APH), Allergy Therapeutics (AGY), and Horizon Discovery Group plc (HZD.L) (HZD). These companies are all part of the "medical" sector.

BATM Advanced Communications vs.

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.6%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.7%. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£130.32M0.73-£278.26K-£0.04-417.87
Tristel£42.24M3.92£6.54M£13.6625.40

In the previous week, Tristel had 2 more articles in the media than BATM Advanced Communications. MarketBeat recorded 3 mentions for Tristel and 1 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 1.50 beat Tristel's score of -0.11 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BATM Advanced Communications
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Tristel
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

BATM Advanced Communications received 42 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.22% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.22%
Underperform Votes
196
50.78%
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%

BATM Advanced Communications has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.

42.4% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 50.4% of Tristel shares are held by institutional investors. 26.2% of BATM Advanced Communications shares are held by insiders. Comparatively, 4.9% of Tristel shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Tristel has a net margin of 15.47% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.43% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.21% -0.22% 0.58%
Tristel 15.47%20.43%9.89%

Summary

Tristel beats BATM Advanced Communications on 10 of the 17 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£95.59M£3.78B£5.84B£2.64B
Dividend Yield3.52%1.99%4.75%4.98%
P/E Ratio-417.8719.9326.04162.45
Price / Sales0.73405.46447.46313,322.68
Price / Cash2.12146.5438.0128.12
Price / Book0.772.717.645.16
Net Income-£278,261.31£99.80M£3.18B£5.75B
7 Day Performance1.69%-1.65%-2.00%-0.99%
1 Month Performance-5.01%0.82%-0.44%-0.80%
1 Year Performance-12.62%-5.49%16.44%39.55%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 18
-0.6%
N/A-14.3%£95.59M£130.32M-417.87980News Coverage
Gap Down
High Trading Volume
TSTL
Tristel
N/AGBX 360
-1.4%
N/A-22.4%£171.97M£42.24M26.35208
SPEC
INSPECS Group
N/AGBX 52
+2.0%
N/A-22.0%£52.87M£195.14M-12.871,673
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.25
-7.1%
N/A+19.7%£7.73M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
1.7317 of 5 stars
GBX 242.60
-0.5%
GBX 301.67
+24.3%
+0.4%£6.17B£2.71B40.8610,000News Coverage
AMS
Advanced Medical Solutions Group
2.371 of 5 stars
GBX 219
-0.5%
GBX 300
+37.0%
+1.2%£472.88M£132.18M42.4410Positive News
APH
Alliance Pharma
2.8485 of 5 stars
GBX 61.40
+0.2%
GBX 6,250
+10,079.2%
+43.6%£332.45M£183.50M-9.9091,000
AGY
Allergy Therapeutics
N/AGBX 6.47
-5.7%
N/A+161.5%£318.01M£72.18M-6.24612
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416

Related Companies and Tools


This page (LON:BVC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners